The global cell therapy market size was US$ 7.88 billion in 2021. The global cell therapy market is forecast to grow to US$ 22.9 billion by 2030 by registering a compound annual growth rate (CAGR) of 13.1% during the forecast period from 2022 to 2030.
In cell therapy, healthy cells are introduced to the patient's body. In this therapy, new cells replace the diseased or missing cells.
Factors Influencing the Market
Cell therapy is getting substantial traction due to the rising prevalence of diseases. In addition to that, the development of precision medicine and growing advancements in cellular therapies leading to high efficiency will fuel the growth of the cell therapy market.
The establishment of efficient stem cell banking facilities will benefit the cell therapy market. Furthermore, technological advancements in the market are expected to surge the demand for cell therapies in the coming years.
The growing range of clinical studies aiming at unveiling the new potential of cellular therapies will boost industry growth. Stem cells are expected to fulfil the unmet demand of the pharmaceutical industry, biotech entities, and doctors. Furthermore, it is expected to help professionals in proper disease management, which will escalate the industry growth during the forecast period. For instance, Lonza (Switzerland) inked a pact with IsoPlexis (USA) in 2020 with the aim to develop the next generation of precision cell therapy.
Government and private funding aiming at amplifying clinical trials will benefit the market. On the contrary, ethical concerns associated with cell therapies may limit the industry's growth during the study period.
COVID-19 Impact Analysis
Demand for cell therapies stayed the same due to rapidly growing R&D activities in the industry during the COVID-19 pandemic. Furthermore, the sudden increase in healthcare expenditure, combined with the rise in the number of private investments, has significantly contributed to the growth of the global cell therapy market.
Regional Analysis
The Asia-Pacific cell therapy market is forecast to grow at the fastest rate, owing to the increasing range of advancements in stem cell therapy. Furthermore, the region is leading in terms of stem cell research, which will contribute to the market growth. In addition to that, rising healthcare expenditure and improving infrastructure in developing economies like China and India will also contribute to the cell therapy market growth. The market may witness untapped potential in the region due to the large regional population and growing prevalence of diseases.
Competitors in the Market
Market Segmentation
The global cell therapy market segmentation focuses on Use, Therapy, and Region.
By Use-Type Outlook
By Therapy Type Outlook
By Regional Outlook
